Adjustment for Inconsistency in Adaptive Phase 2/3 Designs With Dose Optimization
Pharmaceutical Statistics · 2025
DOI: 10.1002/pst.70031 ↗Kurz gefasst
Fachartikel in der Zeitschrift Pharmaceutical Statistics, 2025. Verfasst von Cong Chen und 2 weiteren Autor:innen. Beteiligte Einrichtung: Biostatistics and Research Decision Sciences, Merck & Co., Inc, Rahway, New Jersey, USA. Hauptthemen laut MEDLINE: Research Design, Clinical Trials, Phase II as Topic, Clinical Trials, Phase III as Topic, Antineoplastic Agents. Die Arbeit nennt 9 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Canada Research Chairs, Michael Smith Health Research BC.
Abstract (Originalsprache)
Adaptive Phase 2/3 designs hold great promise in contemporary oncology drug development, especially when limited data from Phase 1 dose‐finding is insufficient for identifying an optimal dose. However, inconsistent results between Phase 2 and Phase 3 may raise regulatory and practical concerns. The imperfection in dose selection further complicates the issue. In this paper, we explicitly incorporate the concerns about inconsistency into the statistical analysis under three hypothesis testing strategies (conservative, aggressive, and neutral) by specifying an inconsistency cutoff and accounting for the probability of “picking‐the‐winner.” This investigation illustrates how to balance regulatory caution, sponsor interests, and practical considerations in adaptive Phase 2/3 designs with dose optimization, which paves the way for further research in a less explored area.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Biostatistics and Research Decision Sciences, Merck & Co., Inc, Rahway, New Jersey, USA.
- Pfizer Inc, Collegeville, Pennsylvania, USA.
- Department of Mathematics and Statistics, University of Victoria, Victoria, British Columbia, Canada.
ORCID-Profile: Xuekui Zhang
Förderung
- Canada Research Chairs
- Michael Smith Health Research BC
Zitieren
APA
Chen, C., Huang, M., & Zhang, X. (2025). Adjustment for Inconsistency in Adaptive Phase 2/3 Designs With Dose Optimization. Pharmaceutical Statistics. https://doi.org/10.1002/pst.70031
Vancouver
Chen C, Huang M, Zhang X. Adjustment for Inconsistency in Adaptive Phase 2/3 Designs With Dose Optimization. Pharmaceutical Statistics. 2025. doi:10.1002/pst.70031
BibTeX
@article{Chen2025,
author = {Chen, Cong and Huang, Mo and Zhang, Xuekui},
title = {Adjustment for Inconsistency in Adaptive Phase 2/3 Designs With Dose Optimization},
journal = {Pharmaceutical Statistics},
year = {2025},
doi = {10.1002/pst.70031}
}
EUVIMED